Using Analytical Platform Technologies to Support Accelerated Product Development—Concept Review and Case Study

References

1. 1.↵
   U.S. Food and Drug Administration, Guidance for Industry: Expedited Programs for Serious Conditions—Drugs and Biologics. Center for Biologics Evaluation and Research. U.S. Department of Health and Human Services: Rockville, MD, 2014.
2. 2.↵
   1. Mire-Sluis A.,
   2. Frazier M.,
   3. May K.,
   4. Lacana L.,
   5. Green N.,
   6. Dye E.,
   7. Krause S.,
   8. Shacter E.,
   9. Reischl I.,
   10. Deshpande R.,
   11. Kutza J.

   Accelerated Product Development: Leveraging Industry and Regulator Knowledge to Bring Products to Patients Quickly. BioProcess Int. 2014, 12.
3. 3.↵
   1. Krause S.

   Risk-Based Analytical Lifecycle Steps for Accelerated Products. CASSS CMC Strategy Meeting, Washington, DC, 2014.
4. 4.↵
   1. Krause S.

   Risk-Based Analytical Lifecycle Steps for Accelerated Products. CASSS CMC Strategy Meeting, Tokyo, Japan, 2014.
5. 5.↵
   1. Krause S.

   Specifications and Analytical Method Lifecycle for Accelerated Biologics. Presentation to CDER/OBP, White Oak, MD, September 28, 2015.
6. 6.↵
   1. Krause S.

   Reducing Analytical Method Lifecycle Steps for Accelerated Products. PDA Letter April 2016.
7. 7.↵
   1. Krause S.

   An Industry Perspective for Analytical Method Validation and Transfer for Biotechnology Product. Presentation to CDER/OBP, NIH Campus, MD, 2012.
8. 8.↵
   Parenteral Drug Association Inc. Technical Report No. 57: Analytical Method Validation and Transfer for Biotechnology Products; Bethesda, MD, 2012.
9. 9.↵
   International Conference for Harmonisation, Guidance for Industry Q2(R1): Validation of Analytical Procedures: Text and Methodology. ICH: Geneva, 2005.
10. 10.↵
    Parenteral Drug Association Inc. Technical Report No. 57-2: Analytical Method Development and Qualification for Biotechnology Products; Bethesda, MD, 2015.
11. 11.↵
    NIST Monoclonal Antibody Reference Material 8671. NIST Web site. https://www.nist.gov/programs-projects/nist-monoclonal-antibody-reference-material-8671 (accessed December 15, 2021).